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Abstract 
Study Design: Retrospective chart review. 
Introduction: De Quervain’s tenosynovitis is a repetitive stress disorder occurring at the first 
dorsal compartment of the wrist at the radial styloid and is commonly treated by hand 
therapists.1-3 Conservative treatments include activity modification, modalities, orthotics, and 
manual therapy.4-7 The literature is unclear regarding best practice for treating de Quervain’s 
tenosynovitis with conservative methods.5,8,9 
Purpose of the study: The purpose of this study was to identify which treatment or treatment 
combinations was most effective to reduce pain and improve functional outcomes for patients 
with de Quervain’s tenosynovitis.  
Methods: A retrospective chart review was conducted with 42 patients seen in outpatient therapy. 
Patient pain was measured using the Numeric Pain Rating Scale (NPRS) and the QuickDASH 
was utilized to assess functional outcomes.10,11  
Results: Both iontophoresis with dexamethasone and therapeutic pulsed (20% or 50%) 
ultrasound (1.0-1.5 w/cm2) were found to have clinical significance as well as statistical 
significance on the QuickDASH (p= 0.028) and NPRS (p= 0.046) respectively. Other treatment 
methods were found to be clinically significant but not statistically significant. Demographics of 
this sample were reflective of the literature as there were 32 women and 10 men.6 The mean age 
of the sample was 39.13 years (range 19-63 years). 
Conclusion: This study demonstrated that iontophoresis with dexamethasone may improve 
functional outcomes while therapeutic pulsed (20% or 50%) ultrasound (1.0-1.5 w/cm 2 ) may be 
effective in decreasing pain in patients with de Quervain’s tenosynovitis.  
Level of Evidence: 4.12 
TREATMENTS FOR DE QUERVAIN’S TENOSYNOVITIS  3 
 
Introduction 
 De Quervain’s tenosynovitis is a condition characterized by inflammation at the first 
dorsal compartment of the wrist at the radial styloid.2 Inflammation affects the extensor pollicis 
brevis (EPB) and abductor pollicis longus (APL) tendons and each of their tendon sheaths and 
may result in thickening of the first dorsal extensor sheath. Individuals who perform repetitive 
activities of the wrist and hand and who repeatedly use their thumbs in grasping and pinching 
motions are most susceptible to de Quervain’s tenosynovitis.3 Population groups at an increased 
risk for the development of de Quervain’s tenosynovitis include: women, parents of young 
children, and individuals with job tasks that involve repetitive movements of the hand and wrist.6 
The main symptom of de Quervain’s tenosynovitis is pain with motions of the wrist or 
thumb.13 Decreased abduction of the carpometacarpal joint of the thumb, palpable thickening of 
the extensor sheath and of the tendons distal to the extensor tunnel, and crepitus of the tendons 
moving through the extensor sheath may also occur.2  Studies have agreed upon diagnostic 
criteria for de Quervain’s tenosynovitis including pain or tenderness over the radial side of the 
wrist and pain reproduced by resisted thumb extension or abduction. In addition, the 
Finkelstein’s test is a physical assessment used to diagnose de Quervain’s tenosynovitis, which is 
administered by folding the thumb across the palm and flexing the fingers over the thumb as the 
wrist is actively or passively deviated toward the ulnar side.5 A positive test results in localized 
pain over the radial styloid and may indicate tenosynovitis of the APL and EPB tendons. Validity 
and reliability of this test has been questioned by several authors.6,13-15 
De Quervain’s tenosynovitis is one of the most common diagnoses treated by 
occupational therapists specializing in hand therapy; therefore, it is imperative that hand/ 
occupational therapists have knowledge of evidence-based tools and techniques specific to de 
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Quervain’s tenosynovitis.1 Conservative occupational therapy treatments for de Quervain’s 
tenosynovitis include, but are not limited to, physical agent modalities (i.e. iontophoresis, 
ultrasound, and fluidotherapy), activity modification, manual therapy, anti-inflammatory 
medications, and a thumb spica or long opponens orthosis.4-7  Although the existing literature 
provides information regarding tools and treatment methods, there is no consensus on the 
appropriate course of treatment for a patient with de Quervain’s tenosynovitis.5,8 Similarly, there 
are no useful evidence-based recommendations for the treatment of de Quervain’s tenosynovitis 
as there are no randomized clinical trials available that assess the effectiveness of conservative 
treatment with this condition.9 Effective treatment of de Quervain’s tenosynovitis using 
fluidotherapy, iontophoresis, and ultrasound therapy is not well supported in the literature, but 
these modalities are commonly used in clinical settings. Activity modification is usually 
addressed following the diagnosis of de Quervain’s tenosynovitis. Activity or worksite 
modifications may include rest, upper extremity orthoses, job and activity modifications, or 
physiotherapy.16 Massage, joint manipulation, and joint stabilization techniques are the most 
common forms of manual therapy for treating de Quervain’s tenosynovitis.17,18 
This retrospective study was a collaboration between a university and a healthcare 
organization that explored the effectiveness of conservative hand/occupational therapy 
treatments and combination of treatments for individuals diagnosed with de Quervain’s 
tenosynovitis. Prior to data collection, this study was approved by two review boards: the 
university review board and the healthcare organization review board. 
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Purpose of the Study 
 The purpose of the study was to identify which treatment or treatment combinations was 
most effective for patients diagnosed with de Quervain’s tenosynovitis.  Effectiveness was 
determined by improvement on the QuickDASH and the Numeric Pain Rating Scale (NPRS).10,11 
Methods 
Design and participants 
 The researchers, who are graduate occupational therapy students, completed a 
retrospective review of 403 electronic medical records and were assisted as needed by clinical 
care providers.  These records were selected for study from the healthcare organization’s 
electronic medical record database for dates of service between January 1, 2009 and January 1, 
2013. Following chart selection, the researchers extracted, de-identified, and entered relevant 
electronic data into a password protected Excel Extraction Tool Spreadsheet. All identifiable 
data were stored on a secure drive only accessible at the healthcare organization. Data collection 
occurred from July 2013 to October 2013 and statistical analysis was completed in November 
2013. A document was created to link patients to the de-identified data for continued reference. 
This document was password protected on a secure server.    
Inclusion criteria 
 The inclusion criteria consisted of the following ICD-9 codes: de Quervain’s 
tenosynovitis (727.04), other tenosynovitis of the hand and wrist (727.05), tenosynovitis-
unspecified (727.00), wrist and hand sprain/strain (842, 842.10), and hand, wrist, and arm pain 
(719.44, 719.43, 729.5); additional evidence (i.e. positive Finkelstein’s test) in the electronic 
medical record indicating de Quervain's tenosynovitis; also, services must have been provided by 
a hand/occupational therapist (Figs. 1 and 2).  
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Exclusion criteria 
 Charts were excluded if the diagnosis code was not one of the ICD-9 codes in the 
inclusion criteria, there was no additional evidence in the chart indicating de Quervain's 
tenosynovitis, the chart was assigned a new diagnosis (not related to de Quervain's tenosynovitis) 
during the course of treatment, the individual was not at least 18 years old at the time of service, 
the date of initial care was not between January 1, 2009 and January 1, 2013, the chart was not 
an occupational therapy chart, or the case was not closed (Fig. 2).  Out of a total of 403 
electronic medical records, 245 were excluded due to a lack of evidence for de Quervain’s 
tenosynovitis, 110 records were excluded because they were not occupational therapy records, 
and 6 records were excluded because the individual was not at least 18 years old at the time of 
service. This left a total of 42 records (Figs. 1 and 2). 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. De Quervain’s tenosynovitis decision algorithm. 
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Fig. 2. Chart determination algorithm. 
Equipment and instruments 
 Treatment effectiveness was determined by a clinically significant improvement on the 
QuickDASH and the NPRS.10,11 The QuickDASH is a short, reliable, and valid measure of 
physical function that pertains to upper-limb musculoskeletal disorders and was adapted from the 
Disabilities of the Arm, Shoulder, and Hand Outcome Measure.11,19,20 Only one study to date has 
assessed the minimum clinically important difference to mark significant improvement from 
clients’ baseline QuickDASH scores.21  A change exceeding eight points indicates a significant 
rate of improvement. The NPRS was used in the present study to identify the level of pain in 
individuals with de Quervain’s tenosynovitis. The NPRS has been deemed reliable and valid.2  
Research indicates that a reduction of approximately two points or approximately 30% from the 
initial pain rating represents a clinically significant improvement.23,24   
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Procedure 
 Data management. Data was retrieved from electronic medical records and entered into 
the password-protected Excel Extraction Tool Spreadsheet, which was available only to the 
researchers. Any electronic transmission of identifiable data was performed over a secure server 
to IRB-approved study personnel. Only de-identified data was shared with other members of the 
research team who were not involved in the data collection process.  
 Provisions to maintain confidentiality. Electronic data were password protected on a 
secure drive only accessible at the healthcare organization. Dates of service were converted to 
whole numbers, with the initial visit considered Day 0, in the Excel Extraction Tool Spreadsheet.  
These whole numbers were used for statistical analysis. De-identified electronic data was stored 
indefinitely for future reference. Identifiable electronic data, including medical record numbers, 
names, dates of birth, and other identifiable information, were deleted from the data set when all 
analyses and publications were complete.  
 Statistical analysis. Statistical analysis of de-identified data was performed by the 
researchers and reviewed by an epidemiologist. Data was analyzed with SPSS 20. Descriptive 
statistics were obtained for all data collected. Chi-squared analysis was performed to determine 
which treatments had a statistically significant difference on the NPRS and the QuickDASH. The 
QuickDASH and NPRS scores for current level of pain considered in this analysis included those 
taken at intake and discharge. 
Results 
 Of the 42 charts selected, there were 32 females (76.2%), 10 males (23.8%), and patients’ 
ages ranged from 19 to 63 years of age, with a mean age of 39.19 years of age (standard 
deviation of 12.74). Thirty-five patients were right hand dominant; however diagnosis frequency 
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was similar between right and left sides, with a diagnosis of left de Quervain’s tenosynovitis for 
15 patients (35.7%), right for 20 patients (47.6%), and bilateral for 7 patients (16.7%). Patients 
sought treatment between two and 225 days following the onset of symptoms, with a mean of  75 
days (standard deviation of 65.73). The mechanism of injury was classified as either sudden 
onset, such as following a fall, a gradual onset, such as a repetitive stress injury from work, or 
pregnancy-related onset. Five patients (13.5%) reported sudden onset, 31 (83.8%) patients 
reported gradual onset, and one subject (2.7%) reported pregnancy-related onset. Symptoms 
reported by patients were classified into the following categories: pain (83.3%), 
catching/popping (4.8%), paresthesias (23.8%), swelling (4.8%), weakness (11.9%), spasms 
(4.8%), and stiffness (2.4%). These categories were not mutually exclusive as patients may have 
experienced multiple symptoms (Table 1).  
Table 1 
Descriptive statistics for the sample and treatments received 
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Fifteen patients (35.7%) reported the use of non-steroidal anti-inflammatory drugs 
(NSAIDs). There were a variety of co-morbid conditions recorded in the charts; however those 
relevant to the de Quervain’s tenosynovitis diagnosis include arthritis (7.1%), CMC arthritis 
(9.6%), previous upper extremity fracture (2.4%), and carpal tunnel syndrome (2.4%). Pertinent 
surgical history of patients included unspecified hand/wrist surgery (4.8%), carpal tunnel 
syndrome release (2.4%), de Quervain’s tenosynovitis corrective surgery (2.4%), and unspecified 
shoulder surgery (4.8%) (Table 2).   
Table 2 
Descriptive statistics for the sample 
 
 
At the time of treatment, 35 patients (94.6%) were employed and two patients (5.4%) 
were students; employment information was not available for five patients. Patients reported 
activity limitations in both activities of daily living (52.4%) and instrumental activities of daily 
living (57.1%) (Table 3). 
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Table 3 
Descriptive statistics for the sample 
 
 
 The five conservative treatments used most frequently by hand/occupational therapists at 
the healthcare organization were selected to be analyzed in greater detail. These treatments 
included therapeutic pulsed ultrasound, iontophoresis with dexamethasone, fluidotherapy, 
manual therapy, and activity modification training.  
 Thirty-two patients (76.2%) received therapeutic pulsed ultrasound at some point during 
the course of treatment. Three out of the 32 patients received only 20% pulsed ultrasound, two 
out of the 32 patients received both 20% and 50% pulsed ultrasound, and 27 out of the 32 
patients received only 50% pulsed ultrasound. The overall range for therapeutic pulsed 
ultrasound frequencies was 0.95-2.15 w/cm2; however, the majority (87.5%) of frequencies 
ranged between 1.0-1.5 w/cm2.  Approximately 68% of patients treated with therapeutic pulsed 
ultrasound showed a clinically significant improvement on the QuickDASH; however, this was 
not statistically significant (p= 0.804). Contrary to the QuickDASH, approximately 44% patients 
who received pulsed ultrasound showed a clinically significant improvement for NPRS current 
level of pain and this improvement was statistically significant (p= 0.046) (Tables 4, 5, 6, 7, and 
8).   
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 Thirty-one patients (73.8%) received iontophoresis with dexamethasone (either with a 
14-hour patch or in-clinic delivery methods) at some point during the course of treatment. 
Approximately 95% of patients who received iontophoresis showed a clinically significant 
improvement on the QuickDASH; this difference was also statistically significant (p= 0.028). 
Approximately 89% of patients who received iontophoresis showed a clinically significant 
improvement for NPRS current level of pain and this improvement was not statistically 
significant (p= 0.186) (Tables 4, 5, 6, 7, and 8). 
 Seventeen patients (40.5%) received fluidotherapy at some point during the course of 
treatment. However, there was not a clinically or statistically significant difference on the 
QuickDASH (p= 0.643) or the NPRS (p= 0.143) (Table 4). 
 Thirty-two patients (76.2%) received manual therapy at some point during the course of 
treatment. Types of manual therapy included cross friction massage, transverse friction massage, 
and soft-tissue massage. Approximately 79% of patients who received manual therapy showed a 
clinically significant improvement on the QuickDASH; however, this was not statistically 
significant (p= 0.698). Approximately 78% of patients who received manual therapy showed a 
clinically significant improvement for NPRS current level of pain and this improvement was not 
statistically significant (p= 0.778) (Tables 4, 5, 6, 7, and 8). 
 Twenty-six (61.9%) patients received activity modification training at some point during 
the course of treatment. Approximately 63% of patients who received activity modification 
training showed a clinically significant improvement on the QuickDASH; however, this was not 
statistically significant (p= 0.282). Approximately 67% of patients who received activity 
modification training showed a clinically significant improvement for NPRS current level of pain 
and this improvement was not statistically significant (p= 0.837) (Tables 4, 5, 6, 7, and 8). 
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Table 4 
Conservative treatments utilized 
Measure Frequency Valid Percent (%) 
Ultrasound     
Yes 32 76.2 
No 10 23.8 
Iontophoresis     
Yes 31 73.8 
No 11 26.2 
Fluidotherapy     
Yes 17 40.5 
No 25 59.5 
Manual Therapy      
 Yes  32 76.2 
No 10 23.8 
Activity Modification     
Yes 26 61.9 
No 16 38.1 
 
 
Table 5 
Statistically significant response to treatment as determined by the QuickDASH 
Treatment P-value 
Iontophoresis  0.028  
Ultrasound 0.804 
Fluidotherapy 0.643 
Manual Therapy 0.698 
Activity Modification 0.282 
 
 
Table 6 
Statistically significant response to treatment as determined by the NPRS for current pain 
Treatment P-value 
Ultrasound  0.046 
Iontophoresis 0.186 
Fluidotherapy 0.143 
Manual Therapy 0.778 
Activity Modification 0.837 
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Table 7  
Clinically significant response to treatment as determined by the QuickDASH (n=30) 
Treatment 
Percent clinically 
significant improvement 
QuickDASH (%) Count 
Iontophoresis 94.7 18 
Manual Therapy 78.9 15 
Ultrasound 68.4 13 
Activity Modification  63.2 12 
Fluidotherapy 36.8 7 
 
 
Table 8 
Clinically significant response to treatment as determined by the NPRS for current pain (n=26) 
Treatment 
Percent clinically 
significant improvement 
NPRS current pain(%) Count 
Iontophoresis  88.9 8 
Manual Therapy 77.8 7 
Activity Modification 66.7 6 
Ultrasound  44.4 4 
Fluidotherapy 44.4 4 
 
Discussion 
 This study examined five conservative occupational therapy treatments in relation to 
clinical outcomes on the QuickDASH and the NPRS. According to the literature review, a 
change exceeding eight points indicates a clinically significant difference on the QuickDASH, 
while a reduction of approximately two points from the initial pain rating represents a clinically 
significant improvement on the NPRS.23,24  For the present study, the clinically significant 
improvement on the QuickDASH from the initial visit to discharge ranged from 9.09 to 81.73. 
The clinically significant improvement on the NRPS ranged from 2 to 6 points. Among other 
findings, the present study identified two statistically significant treatment methods: 
iontophoresis with dexamethasone and therapeutic pulsed (20% or 50%) ultrasound (1.0 -1.5 
w/cm2).   
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Primary findings 
 Iontophoresis. The patients who received iontophoresis with dexamethasone 
demonstrated a clinically and statistically significant improvement on the QuickDASH. Both the 
patch applied in-clinic and worn at home for 14 hours, as well as in-clinic delivery methods with 
a 40mA/min dosage were utilized. This finding  may be important for  therapists treating de 
Quervain’s tenosynovitis because of the significant improvement on the QuickDASH. 
 Ultrasound. The patients who received therapeutic pulsed ultrasound demonstrated a 
clinically and statistically significant improvement on the NPRS for current levels of pain. Only 
therapeutic pulsed (20% or 50%) ultrasound was utilized, and frequencies between 1.0 and 1.5 
w/cm2 were employed with 87.5% of the patients. Pain management is a key role for 
hand/occupational therapists and is necessary for the patient to return to daily occupations.3,6 
This finding is important for occupational therapists in that ultrasound appeared to play a role in 
clinically and statistically significant pain reduction which can facilitate participation in daily 
activities.  
 Manual therapy. Thirty-two of the 42 patients received manual therapy at some point 
during the course of treatment. While there was not a statistically significant difference found, 
79% of patients who received manual therapy showed a clinically significant improvement on 
the QuickDASH and 78% of patients who received manual therapy showed a clinically 
significant improvement for NPRS current level of pain. These findings indicate that 
occupational therapists frequently treat de Quervain’s tenosynovitis with manual therapy, and 
further research is needed to determine (a) its effectiveness and (b) which specific type of 
manual therapy treatment (i.e. soft tissue massage, cross friction massage, or transverse friction 
massage) is the most effective.   
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 Activity modification. Activity modification is an area of practice frequently targeted by 
hand/occupational therapists.25 In the present study, a large number of patients (63%) who 
received activity modification training showed a clinically significant improvement on the 
QuickDASH and 67% of patients who received activity modification training showed a clinically 
significant improvement for NPRS current level of pain; however, no statistical significance was 
found. Effectiveness of activity modification is an important consideration for further research.  
Secondary findings 
 According to the literature, a thumb spica orthosis is primarily utilized to provide rest for 
the APL and EPB tendons. 3,6 In the present study, the majority of patients were provided with a 
pre-fabricated orthosis by their physician prior to beginning treatment. Few patients received  
orthotics during the course of treatment. Of the small number (9) of orthotics distributed, the 
majority of patients (80%) were fitted with a neoprene thumb spica orthosis, while the remaining 
patients were provided with a custom fabricated thermoplastic thumb spica orthosis. The 
flexibility of neoprene orthotics allows for some movement of the thumb, which may not 
completely rest the APL and EPB tendons.26 Additionally, no information regarding compliance 
was documented following distribution of the orthoses, and, as a result, it is difficult to determine 
the effectiveness of the use of orthoses with the present study. Further research is needed, 
especially in the area of rigid orthoses and de Quervain’s tenosynovitis.   
Strengths and limitations 
 While the researchers are current graduate occupational therapy students, they were 
closely mentored by academic research advisors and other experienced clinicians. Although data 
was collected by the three researchers, the decision algorithm ensured a consistent process to 
accurately include charts based on a diagnosis of de Quervain’s tenosynovitis. Furthermore, valid 
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and reliable outcome tools (the QuickDash and the NPRS) were utilized. Despite the small 
sample size, clinical and statistical significance were demonstrated in the improvement of pain 
symptoms and function.  
 The limitations of this study are inherent to the retrospective design and small sample 
size. Information regarding discharge was limited, there were notable differences in clinician 
documentation, and information related to overall subject treatment compliance, which was 
unavailable in many cases. Another limitation to consider was the patients’ use of NSAIDs.  
Fifteen of the 42 patients reported the use of NSAIDs at intake. It was unclear if NSAID use 
continued or was later initiated during the course of treatment, or if NSAID use was a 
contributing factor to improvement. Finally, the sample was selected from a single healthcare 
organization and therefore may not be generalizable. 
Conclusion 
 The clinical contribution of the present study was demonstrating the effectiveness of two 
conservative treatment methods for de Quervain’s tenosynovitis. Iontophoresis with 
dexamethasone was shown to be both clinically and statistically significant as evidenced by 
improvement on QuickDASH scores, while therapeutic pulsed (20 and/or 50%) ultrasound (1.0-
1.5 w/cm2) was shown to be both clinically and statistically significant as evidenced by 
improvement on NPRS current level of pain scores. This may demonstrate the efficacy of 
iontophoresis with dexamethasone and pulsed (20% or 50%) ultrasound (1.0 –1.5 w/cm2) in the 
treatment of de Quervain’s tenosynovitis. Further research is needed that focuses on 
iontophoresis administration (i.e. 14-hour patch versus in-clinic delivery methods and 
corresponding dosages), activity modification, manual therapy, and the use of orthotics. In 
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addition, studies with larger sample sizes that include information regarding patient compliance 
with each treatment is recommended.  
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